The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. (Q37995919)

26 August 2017

title

The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. (English)

1 reference

26 August 2017

0 references

4

1 reference

26 August 2017

Sybille Böhm

1

1 reference

26 August 2017

Inessa Schwab

series ordinal

2

1 reference

26 August 2017

Anja Lux

series ordinal

3

1 reference

26 August 2017

publication date

22 March 2012

1 reference

Seminars in Immunopathology

26 August 2017

published in

1 reference

26 August 2017

volume

34

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

443-453

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-012-0308-x

26 August 2017

exact match

0 references

cites work

Antibody-mediated modulation of immune responses.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Fc receptors are major mediators of antibody based inflammation in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Fcgamma receptors as regulators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Fc receptor but not complement binding is important in antibody protection against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Analyzing antibody-Fc-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Immune inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Divergent immunoglobulin g subclass activity through selective Fc receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Anti-inflammatory actions of intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Intravenous immunoglobulins--understanding properties and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Multiple roles for the major histocompatibility complex class I- related receptor FcRn

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Antibody therapeutics: isotype and glycoform selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

New insight into the mechanism of action of IVIg: the role of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

The impact of glycosylation on the biological function and structure of human immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Glycosylation and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Terminal sugars of Fc glycans influence antibody effector functions of IgGs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Pairing of oligosaccharides in the Fc region of immunoglobulin G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

The structure of a human type III Fcgamma receptor in complex with Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Fc-glycosylation of IgG1 is modulated by B-cell stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Abnormal IgG galactosylation in MRL-lpr/lpr mice: pathogenic role in the development of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Agalactosyl glycoforms of IgG autoantibodies are pathogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Arthritis critically dependent on innate immune system players

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

The role of complement and complement receptors in induction and regulation of immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Mannose-binding lectin does not explain the course and outcome of pregnancy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

A close look at human IgG sialylation and subclass distribution after lectin fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Identification of a receptor required for the anti-inflammatory activity of IVIG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Fcgamma receptors: old friends and new family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Contrasting IgG Structures Reveal Extreme Asymmetry and Flexibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Agalactosyl IgG is elevated in patients with active spondyloarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

The role of oil and agalactosyl IgG in the induction of arthritis in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

A comparative analysis of disease-associated changes in the galactosylation of serum IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0308-X

Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum

21 January 2018

1 reference

12 December 2020

Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region

1 reference

12 December 2020

Decreased B-cell galactosyltransferase activity in rheumatoid arthritis

1 reference

12 December 2020

Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity

1 reference

12 December 2020

Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry

1 reference

12 December 2020

Structural changes in the oligosaccharide moiety of human IgG with aging

1 reference

12 December 2020

Divergent roles for Fc receptors and complement in vivo

1 reference

12 December 2020

The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment

1 reference

12 December 2020

Analytical and Functional Aspects of Antibody Sialylation.

1 reference

12 December 2020

Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis

1 reference

12 December 2020

Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans

1 reference

12 December 2020

Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study

1 reference

12 December 2020

Galactosylation of IgG from rheumatoid arthritis (RA) patients--changes during therapy

1 reference

12 December 2020

Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics

1 reference

12 December 2020

Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro

1 reference

12 December 2020

The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G

1 reference

12 December 2020

Roles of Fc receptors in autoimmunity

1 reference

12 December 2020

Agalactosyl IgG: an aid to differential diagnosis in early synovitis

1 reference

12 December 2020

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

1 reference

12 December 2020

The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis

1 reference

12 December 2020

The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H

1 reference

12 December 2020

Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein

1 reference

12 December 2020

The glycosylation of red cell autoantibodies affects their functional activity in vitro

1 reference

12 December 2020

Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis

1 reference

12 December 2020

Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.

1 reference

12 December 2020

Analysis of different glycosylation states in IgG subclasses

1 reference

12 December 2020

Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis

1 reference

12 December 2020

Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC

1 reference

12 December 2020

Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.

1 reference

12 December 2020

Abnormal glycosylation of serum igg from patients with chronic inflammatory diseases

1 reference

12 December 2020

10.1007/S00281-012-0308-X

Identifiers

DOI

1 reference

26 August 2017

1 reference